GlassScriptPhysician profile
Dana P Edwards
NPI 1164424131
$2,537.95
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $527 · 2020: $353 · 2021: $654 · 2022: $619 · 2023: $155 · 2024: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $384.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $980.09 | 2019-2024 | Relistor, Xifaxan |
| Redhill Biopharma INC. | $423.42 | 2020-2023 | Talicia, Aemcolo, Movantik |
| Abbvie INC. | $323.80 | 2021-2024 | Mavyret |
| Amgen INC. | $140.75 | 2019-2022 | |
| Davol INC. | $130.70 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $108.76 | 2019-2021 | |
| Indivior INC. | $81.72 | 2019-2024 | Sublocade |
| Axsome Therapeutics, INC. | $43.52 | 2024 | Auvelity |
| Biodelivery Sciences International, INC. | $40.78 | 2019-2021 | |
| Allergan, INC. | $31.58 | 2019-2020 | |
| Boston Scientific Corporation | $27.13 | 2023 | Rezum Generator |
| Daiichi Sankyo INC. | $25.03 | 2019 | |
| Philips North America LLC | $22.53 | 2019 | |
| Pfizer INC. | $20.67 | 2024 | |
| Innocoll Pharmaceuticals Limited | $19.86 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $17.48 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.77 | 2022 | |
| Smith+Nephew, INC. | $15.29 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.18 | 2019 | |
| Medtronic, INC. | $14.27 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $13.52 | 2023 | Dupixent |
| Osiris Therapeutics INC. | $13.43 | 2019 | |
| Novo Nordisk INC | $12.67 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.